Passage Bio Inc. (NASDAQ: PASG)
$0.8171
-0.0119 ( -0.23% ) 263.5K
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
Market Data
Open
$0.8171
Previous close
$0.8290
Volume
263.5K
Market cap
$46.94M
Day range
$0.7660 - $0.8730
52 week range
$0.4510 - $1.7900
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Oct 02, 2024 |
4 | Insider transactions | 1 | Sep 23, 2024 |
4 | Insider transactions | 1 | Sep 18, 2024 |
8-k | 8K-related | 47 | Sep 16, 2024 |
8-k | 8K-related | 13 | Sep 10, 2024 |
8-k | 8K-related | 13 | Sep 06, 2024 |
3 | Insider transactions | 1 | Aug 09, 2024 |
10-q | Quarterly Reports | 64 | Aug 08, 2024 |
8-k | 8K-related | 45 | Aug 08, 2024 |
8-k | 8K-related | 13 | Aug 02, 2024 |